Evolutionary routes and KRAS dosage define pancreatic cancer phenotypesSebastian Mueller, Roland Rad, Thomas Engleitner et al.|Nature|2018Cited by 455
CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in miceJulia Weber, Roland Rad, Rupert Öllinger et al.|Proceedings of the National Academy of Sciences|2015Cited by 195
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeuticallyEnkhtsetseg Munkhbaatar, Philipp J. Jost, Martijn van Griensven et al.|Nature Communications|2020Cited by 62
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identificationCelina Tretter, Angela M. Krackhardt, Niklas de Andrade Krätzig et al.|Nature Communications|2023Cited by 49
Morphology MattersMoritz Jesinghaus, Wilko Weichert, Maxime Schmitt et al.|The American Journal of Surgical Pathology|2021Cited by 42